“`html
On Wednesday, the First Trust NYSE Arca Biotechnology Index Fund ETF increased by approximately 3.7%. Key performers within the fund included shares of Moderna, which rose by 8.8%, and Regeneron Pharmaceuticals, up 8.3%.
In contrast, the VanEck BDC Income ETF declined by about 3.9%. Notable underperformers in this ETF were Sixth Street Specialty Lending, down 2.2%, and Morgan Stanley Direct Lending Fund, which fell by 1.7%.
“`
